Page 12 - Jessica Ellsworth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

joe daniel price/Getty Images(WASHINGTON) The U.S. Supreme Court on Tuesday heard a challenge to the Food and Drug Administration s regulation of mifepristone, a widely used drug used in medication abortions.In what was the most significant reproductive rights case brought before the high court since its conservative majority overruled Roe v. Wade in 2022, most of the justices, across ideological lines, appeared skeptical of restricting access to the abortion pill nationwide and repeatedly questioned whether the group of anti-abortion doctors who brought the case had standing to sue and seek such a sweeping remedy.A decision in the case is expected by the end of June.Here are five key takeaways from the roughly two hours of arguments.Standing at center of debate: You need a person The arguments largely revolved around whether the anti-abortion plaintiffs, the Alliance for Hippocratic Medicine, had standing to bring this case specifically whether their clients had suffered the kind

United statesJustice amy coney barrettElizabeth prelogarJessica ellsworthJustice ketanji brown jacksonErin hawleyClarence thomasJustice elena kaganJustice jacksonMatthew kacsmarykNeil gorsuchJustice samuel alitoUnited states postal serviceAlliance for hippocratic medicineUs circuit courtSupreme court